News
Academy
Editorial PodcastsEditorial VideosProfiles in Medicine
Conference CoverageConference Listing
Pharmaceutical Executive
Partner Perspectives
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers
Subscribe
Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
Spotlight -
  • Pharmaceutical Executive APEX Awards
  • Latest Executive Roundtables
  • Asembia 2025
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Academy
    • Partner Perspectives
    • Subscribe
Advertisement

Celebrating Innovation: Prix Galien Photo Gallery

November 1, 2007
By Joanna Breitstein
Article

Pharmaceutical Executive

Pharmaceutical ExecutivePharmaceutical Executive-11-01-2007
Volume 0
Issue 0

Photos from the awards ceremony of the first US Prix Galien, September 25, 2007 in New York City.

The Prix Galien Awards were established more than 30 years ago in France to honor research innovation within the pharmaceutical industry. Since their creation, the awards have expanded to other countries around the globe. This year marked the first time the Prix Galien Awards honored American innovation. The black-tie event—held on Sept. 25, 2007, at New York City's swank Cipriani—was truly a star-studded affair, presided over by television personality Charlie Rose and featuring a special appearance by author and Nobel Peace Prize laureate Elie Wiesel. Medals were awarded by an esteemed panel of judges, including the six Nobel laureates in attendance. Pfizer's Chantix and Merck's Januvia took home awards for best pharmaceutical product, and Abbott Labs' Humira and Merck's Gardasil won in the biotech class—but a good time was had by all.

Articles in this issue

i1-469184-1408674973468.jpg
More Confidence—or Slower Development?
FDA's Approvable Problem
FDA's Approvable Problem
Step It Up: Branding Roundtable
Step It Up: Branding Roundtable
Rx Club Awards: Human Interest
Rx Club Awards: Human Interest
i4-469187-1408674949706.jpg
The Intelligence Diaries
fromtheeditor_thumbnail-469181-1408674996048.jpg
Chasing Perfection
Celebrating Innovation: Prix Galien Photo Gallery
Celebrating Innovation: Prix Galien Photo Gallery
From 3-D to Pop-ups: Go Dimensional
From 3-D to Pop-ups: Go Dimensional
i1-469185-1408674966813.jpg
India vs. China
Reach KOLs Online
Reach KOLs Online
i1-469182-1408674989211.jpg
Preemption Preview: Q&A with Mark Herrmann, Jones Day
i1-469183-1408674976730.jpg
Welcome Some Disruption in Your Life
Recent Videos
Related Content

© JHVEPhoto - ©  JHVEPhoto - stock.adobe.com

FDA Outlines Updated Requirement for Placebo-Controlled Trials in Vaccine Research

Andy Studna
May 21st 2025
Article

In an article recently published by The New England Journal of Medicine, FDA higher-ups Vinay Prasad, MD, MPH; and Martin A. Makary, MD, MPH, wrote that any new COVID-19 vaccine must now be evaluated in placebo-controlled studies.


Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research

Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research

Miranda Schmalfuhs
April 14th 2025
Podcast

LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.


FDA Advisory Committee Backs J&J’s Darzalex Faspro for High-Risk Smoldering Multiple Myeloma

FDA Advisory Committee Backs J&J’s Darzalex Faspro for High-Risk Smoldering Multiple Myeloma

Don Tracy, Associate Editor
May 21st 2025
Article

Positive feedback was based on Phase III AQUILA trial results, which showed a significant clinical benefit with Darzalex Faspro in patients with high-risk smoldering multiple myeloma.


Beyond the Prescription: Pharma's Role in Digital Health Conversations

Beyond the Prescription: Pharma's Role in Digital Health Conversations

Canopy
April 1st 2025
Podcast

Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.


Christopher Wooden

The Promise of Agentic AI to Cut Through HCP Marketing Overwhelm

Christopher Wooden
May 21st 2025
Article

Prioritizing deeper customer insights helps life sciences marketers understand how to engage their HCP audiences effectively with the right message.


Pfizer, 3SBio Forge Licensing Pact for SSGJ-707 to Target Lung, Colorectal, and Gynecologic Cancers

Pfizer, 3SBio Forge Licensing Pact for SSGJ-707 to Target Lung, Colorectal, and Gynecologic Cancers

Don Tracy, Associate Editor
May 20th 2025
Article

Under terms of the deal, Pfizer will gain rights to develop, manufacture, and commercialize SSGJ-707 outside of China.

Related Content

© JHVEPhoto - ©  JHVEPhoto - stock.adobe.com

FDA Outlines Updated Requirement for Placebo-Controlled Trials in Vaccine Research

Andy Studna
May 21st 2025
Article

In an article recently published by The New England Journal of Medicine, FDA higher-ups Vinay Prasad, MD, MPH; and Martin A. Makary, MD, MPH, wrote that any new COVID-19 vaccine must now be evaluated in placebo-controlled studies.


Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research

Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research

Miranda Schmalfuhs
April 14th 2025
Podcast

LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.


FDA Advisory Committee Backs J&J’s Darzalex Faspro for High-Risk Smoldering Multiple Myeloma

FDA Advisory Committee Backs J&J’s Darzalex Faspro for High-Risk Smoldering Multiple Myeloma

Don Tracy, Associate Editor
May 21st 2025
Article

Positive feedback was based on Phase III AQUILA trial results, which showed a significant clinical benefit with Darzalex Faspro in patients with high-risk smoldering multiple myeloma.


Beyond the Prescription: Pharma's Role in Digital Health Conversations

Beyond the Prescription: Pharma's Role in Digital Health Conversations

Canopy
April 1st 2025
Podcast

Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.


Christopher Wooden

The Promise of Agentic AI to Cut Through HCP Marketing Overwhelm

Christopher Wooden
May 21st 2025
Article

Prioritizing deeper customer insights helps life sciences marketers understand how to engage their HCP audiences effectively with the right message.


Pfizer, 3SBio Forge Licensing Pact for SSGJ-707 to Target Lung, Colorectal, and Gynecologic Cancers

Pfizer, 3SBio Forge Licensing Pact for SSGJ-707 to Target Lung, Colorectal, and Gynecologic Cancers

Don Tracy, Associate Editor
May 20th 2025
Article

Under terms of the deal, Pfizer will gain rights to develop, manufacture, and commercialize SSGJ-707 outside of China.

About
Advertise
Contact Us
Editorial Board
Editorial Submission Guidelines
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.